The COVID-19 Pandemic Led to a Small Increase in Changed Mentality Regarding Infection Risk without Any Change in Willingness to Be Vaccinated in Chronic Diseases Patients.

COVID-19 pandemic chronic disease infection risk people living with diabetes vaccination coverage

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 29 07 2021
revised: 25 08 2021
accepted: 01 09 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

The objective of this study was to assess the impact of the COVID-19 pandemic on patients' perceptions regarding infection risk and vaccination in subjects suffering from chronic diseases. A prospective observational multicentric study conducted from December 2020 to April 2021 in three French University Hospitals. Patients with chronic diseases were proposed to complete a questionnaire regarding the impact of the COVID-19 pandemic on infectious risk knowledge and vaccination. A total of 1151 patients were included and analyzed (62% of which were people with diabetes). The COVID-19 pandemic increased awareness of infectious risks by 19.3%, significantly more in people with diabetes (23.2%, from 54.4% to 67.0%,

Identifiants

pubmed: 34501415
pii: jcm10173967
doi: 10.3390/jcm10173967
pmc: PMC8432078
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Gen Intern Med. 2020 Nov;35(11):3285-3292
pubmed: 32875509
Ann Palliat Med. 2021 May;10(5):5069-5083
pubmed: 33894729
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Diabetes Res Clin Pract. 2020 Sep;167:108350
pubmed: 32710996
Ann Intern Med. 2020 Jul 21;173(2):100-109
pubmed: 32271861
J Public Health (Oxf). 2021 Mar 09;:
pubmed: 33693905
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
Am J Infect Control. 2021 May;49(5):640-642
pubmed: 33031863
J Med Internet Res. 2020 May 6;22(5):e19458
pubmed: 32352383
Int J Environ Res Public Health. 2021 Jan 23;18(3):
pubmed: 33498701
PLoS One. 2021 May 12;16(5):e0251694
pubmed: 33979413
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Vaccine. 2015 Jun 4;33(24):2741-56
pubmed: 25936726
Int J Infect Dis. 2021 May;106:323-328
pubmed: 33794382
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
Health Econ. 2019 Nov;28(11):1377-1382
pubmed: 31429153
BMJ. 2019 Jul 3;366:l4457
pubmed: 31270071
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Diabetes Care. 2003 Feb;26(2):510-3
pubmed: 12547890
Diabetes Care. 2004 Jan;27 Suppl 1:S111-3
pubmed: 14693944
PLoS One. 2021 May 3;16(5):e0250602
pubmed: 33939733
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Technol Forecast Soc Change. 2021 May;166:120592
pubmed: 33776154
SN Compr Clin Med. 2020 Jul 28;:1-6
pubmed: 32838177
BMJ Open. 2020 Dec 29;10(12):e045309
pubmed: 33376185
Hum Vaccin Immunother. 2018 Jul 3;14(7):1654-1659
pubmed: 29553872
J Med Internet Res. 2020 Jun 16;22(6):e19782
pubmed: 32501801
Diabetes Care. 2019 Jan;42(Suppl 1):S34-S45
pubmed: 30559230
Diabetologia. 2020 Aug;63(8):1500-1515
pubmed: 32472191
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528

Auteurs

Cyril Breuker (C)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.
PhyMedExp, CHU Montpellier, INSERM, CNRS, University of Montpellier, 34295 Montpellier, France.

Anne Marie Guedj (AM)

Department of Endocrinology, University Hospital of Nîmes, 30900 Montpellier, France.

Mathilde Allan (M)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Loick Coinus (L)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Nicolas Molinari (N)

Department of Statistics, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Nicolas Chapet (N)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

François Roubille (F)

Department of Cardiology, PhyMedExp, CHU Montpellier, INSERM, CNRS, University of Montpellier, 34295 Montpellier, France.

Moglie Le Quintrec (M)

Department of Nephrology, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Véronique Duhalde (V)

Department of Pharmacy, Toulouse University Hospital, 31300 Toulouse, France.

Julien Jouglen (J)

Department of Pharmacy, Toulouse University Hospital, 31300 Toulouse, France.

Philippe Cestac (P)

Department of Pharmacy, Toulouse University Hospital, 31300 Toulouse, France.
Centre for Epidemiology and Population Health Research (CERPOP), UMR 1027, INSERM, University of Toulouse (UPS), 31000 Toulouse, France.

Jean Marie Kinowski (JM)

Department of Pharmacy, CHU Nîmes, 30000 Nîmes, France.

Stéphanie Faure (S)

Department of Gastroenterology, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Marie Faucanie (M)

Clinical Research and Epidemiology Unit, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Laura Lohan (L)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.
PhyMedExp, CHU Montpellier, INSERM, CNRS, University of Montpellier, 34295 Montpellier, France.

Maxime Villiet (M)

Department of Clinical Pharmacy, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Romain Altwegg (R)

Department of Gastroenterology, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Ariane Sultan (A)

PhyMedExp, CHU Montpellier, INSERM, CNRS, University of Montpellier, 34295 Montpellier, France.
Department of Endocrinology-Diabetology-Nutrition, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.

Classifications MeSH